0001193125-21-040449.txt : 20210212 0001193125-21-040449.hdr.sgml : 20210212 20210212100428 ACCESSION NUMBER: 0001193125-21-040449 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Kindred Biosciences, Inc. CENTRAL INDEX KEY: 0001561743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461160142 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87768 FILM NUMBER: 21623662 BUSINESS ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-701-7901 MAIL ADDRESS: STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200 CITY: BURLINGAME STATE: CA ZIP: 94010 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AMERIPRISE FINANCIAL INC CENTRAL INDEX KEY: 0000820027 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 133180631 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1099 AMERIPRISE FINANCIAL CENTER CITY: MINNEAPOLIS STATE: MN ZIP: 55474 BUSINESS PHONE: 612-671-8001 MAIL ADDRESS: STREET 1: 1099 AMERIPRISE FINANCIAL CENTER CITY: MINNEAPOLIS STATE: MN ZIP: 55474 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN EXPRESS FINANCIAL CORP DATE OF NAME CHANGE: 20030513 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN EXPRESS FINANCIAL ADVISORS DATE OF NAME CHANGE: 19950711 FORMER COMPANY: FORMER CONFORMED NAME: IDS FINANCIAL CORP/MN/ DATE OF NAME CHANGE: 19920703 SC 13G 1 d124374dsc13g.htm SC 13G SC 13G

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities and Exchange Act of 1934

 

 

Kindred Biosciences Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

494577109

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

This Schedule is filed pursuant to Rule 13d-1(b)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 

CUSIP NO. 494577109

 

  1)    

  Name of Reporting Person

  Ameriprise Financial, Inc.

 

  S.S. or I.R.S. Identification No. of Above Person

  IRS No. 13-3180631

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

*  This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

      5)     

  Sole Voting Power

 

  0

     6)   

  Shared Voting Power

 

  1,985,418

     7)   

  Sole Dispositive Power

 

  0

     8)   

  Shared Dispositive Power

 

  1,986,158

9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  1,986,158

10)   

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)   

  Percent of Class Represented by Amount In Row (9)

 

  5.05%

12)   

  Type of Reporting Person

 

  HC

1(a)    Name of Issuer:    Kindred Biosciences Inc
1(b)    Address of Issuer’s Principal    1555 Bayshore Highway, Suite 200
   Executive Offices:    Burlingame, California 94010
2(a)    Name of Person Filing:    Ameriprise Financial, Inc. (“AFI”)
2(b)    Address of Principal Business Office:    Ameriprise Financial, Inc.
      145 Ameriprise Financial Center
      Minneapolis, MN 55474
2(c)    Citizenship:    Delaware
2(d)    Title of Class of Securities:    Common Stock
2(e)    Cusip Number:    494577109
3    Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):
  

Ameriprise Financial, Inc.

   A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
4    Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.
   AFI disclaims beneficial ownership of any shares reported on this Schedule.
5    Ownership of 5% or Less of a Class: Not Applicable
6    Ownership of more than 5% on Behalf of Another Person: Not Applicable
7    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
  

AFI: See Exhibit I

8    Identification and Classification of Members of the Group:
  

Not Applicable

9    Notice of Dissolution of Group:
  

Not Applicable

10   

Certification:

 

   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 12, 2021

 

    Ameriprise Financial, Inc.
                                                      By:  

/s/ Paul Goucher

    Name:   Paul Goucher
    Title:   Senior Vice President and Assistant

General Counsel

 

        Contact Information
        Mark D. Braley
        Vice President
       

Head of Reporting and Data Management |

Global Operations and Investor Services

        Telephone: (617) 747-0663

Exhibit Index

 

Exhibit I    Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.

 

 EX-99.I 2 d124374dex99i.htm EX-99.I EX-99.I

Exhibit I

to

Schedule 13G

Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows:

Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940.